# | Title | Journal | Year | Citations |
---|
1 | A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors | Aids | 1998 | 2,138 |
2 | Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS | Aids | 2009 | 1,751 |
3 | Dynamics of HIV viremia and antibody seroconversion in plasma donors | Aids | 2003 | 1,107 |
4 | Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies | Aids | 2006 | 1,053 |
5 | Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women | Aids | 1993 | 1,045 |
6 | Stigma in the HIV/AIDS epidemic: a review of the literature and recommendations for the way forward | Aids | 2008 | 996 |
7 | Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA | Aids | 2006 | 935 |
8 | Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population | Aids | 2000 | 905 |
9 | Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis | Aids | 2009 | 825 |
10 | Review of sampling hard-to-reach and hidden populations for HIV surveillance | Aids | 2005 | 820 |
11 | Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders | Aids | 2011 | 818 |
12 | Concurrent partnerships and the spread of HIV | Aids | 1997 | 810 |
13 | Non-adherence to highly active antiretroviral therapy predicts progression to AIDS | Aids | 2001 | 802 |
14 | Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study | Aids | 2003 | 770 |
15 | Adverse effects of reverse transcriptase inhibitors | Aids | 1998 | 760 |
16 | Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review | Aids | 2006 | 757 |
17 | Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients | Aids | 2001 | 743 |
18 | Effectiveness and safety of oral HIV preexposure prophylaxis for all populations | Aids | 2016 | 721 |
19 | Trends in cancer risk among people with AIDS in the United States 1980–2002 | Aids | 2006 | 653 |
20 | Persistent immune activation in HIV-1 infection is associated with progression to AIDS | Aids | 2003 | 624 |
21 | Form, function, and use of retroviral Gag proteins | Aids | 1991 | 614 |
22 | Estimating per-act HIV transmission risk | Aids | 2014 | 609 |
23 | Global trends in molecular epidemiology of HIV-1 during 2000–2007 | Aids | 2011 | 602 |
24 | Cognitive dysfunction in HIV patients despite long-standing suppression of viremia | Aids | 2010 | 592 |
25 | Needle exchange is not enough | Aids | 1997 | 583 |
26 | Risk factors for HIV infection among men who have sex with men | Aids | 2006 | 577 |
27 | Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies | Aids | 2008 | 577 |
28 | Bacterial vaginosis and disturbances of vaginal flora | Aids | 1998 | 570 |
29 | Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa | Aids | 2008 | 564 |
30 | Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy | Aids | 2005 | 553 |
31 | Immune restoration disease after antiretroviral therapy | Aids | 2004 | 542 |
32 | Sociodemographic and psychological variables influencing adherence to antiretroviral therapy | Aids | 1999 | 540 |
33 | The prevalence and incidence of neurocognitive impairment in the HAART era | Aids | 2007 | 539 |
34 | A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome | Aids | 2000 | 538 |
35 | A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy | Aids | 1999 | 520 |
36 | Explaining disparities in HIV infection among black and white men who have sex with men: a meta-analysis of HIV risk behaviors | Aids | 2007 | 516 |
37 | Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004 | Aids | 2006 | 496 |
38 | Estimating the proportion of HIV transmissions from main sex partners among men who have sex with men in five US cities | Aids | 2009 | 496 |
39 | The mortality and pathology of HIV infection in a West African city | Aids | 1993 | 493 |
40 | Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis | Aids | 2000 | 490 |
41 | Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients | Aids | 2000 | 483 |
42 | The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response | Aids | 1999 | 481 |
43 | Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000–2006 | Aids | 2008 | 479 |
44 | Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men | Aids | 2003 | 477 |
45 | Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa | Aids | 2004 | 475 |
46 | Young people's sexual health in South Africa: HIV prevalence and sexual behaviors from a nationally representative household survey | Aids | 2005 | 473 |
47 | Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort | Aids | 2005 | 472 |
48 | Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection | Aids | 2000 | 468 |
49 | Early exclusive breastfeeding reduces the risk of postnatal HIV-1 transmission and increases HIV-free survival | Aids | 2005 | 463 |
50 | Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy | Aids | 2000 | 455 |